HANEY CECIL D 4

What Happened

• Cecil D. Haney, a director of Tenet Healthcare Corporation (THC), was granted 1,188 restricted stock units (RSUs) on 2026-05-27. The Form 4 reports these as an award (code A) with a per-unit price of $0.00 (typical reporting for RSU grants); the filing was submitted 2026-05-28.
• RSUs are a type of derivative award that convert into common shares (or cash) upon vesting. This grant is compensation/retention-related rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-27; Form 4 filed: 2026-05-28 (appears timely — Form 4 is generally due within 2 business days).
• Award: 1,188 restricted stock units reported at $0.00 per unit (reported value on Form 4, not the market value).
• Vesting: RSUs vest on the first anniversary of the grant date (i.e., around 2027-05-27).
• Cash election/tax: The reporting person may elect to receive up to 37% of the RSUs in cash in lieu of shares (commonly used for tax withholding).
• Shares owned after transaction: not specified in the provided excerpt.

Context

• RSUs are compensation awards that become ordinary shares (or cash) when they vest; they do not represent an immediate open-market purchase or sale and therefore are not a direct bullish/sell signal.
• For retail investors, such grants are routine for directors and are primarily a retention/compensation mechanism. The economic value to the insider will depend on Tenet’s stock price at vesting.